632. A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial Evaluating Two Dose Regimens of Rifaximin (550mg daily or twice-daily) for Chemoprophylaxis Against Travelers’ Diarrhea Among Deployed U.S. and U.K. Military Personnel (PREVENT TD)

BACKGROUND: Travelers’ diarrhea (TD) is a leading threat to military readiness. Most trials of rifaximin chemoprophylaxis involve civilians or short-duration travel, whereas military travelers are exposed for longer periods at austere locations and are often physically taxed. We sought to assess eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutierrez, Ramiro L, Burns, Daniel, Lalani, Tahaniyat, Bennett-Carter, Denise, Fraser, Jamie, Riddle, Mark, Connor, Patrick, Porter, Chad, Troth, Thomas, Ruck, Richard, Barton, Jerry, Tilley, Drake H, Kunz, Anjali, Fairchok, Mary, Yun, Heather, Alvarez, Bryan, Higgins, Robert, Mitra, Indrani, Stewart, Laveta, Rahman, Azizur, Rimmer, JoAnna, Hutley, Emma, Swierczewski, Brett, Tabberer, Bethany, Tribble, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777655/
http://dx.doi.org/10.1093/ofid/ofaa439.826

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777655/
http://dx.doi.org/10.1093/ofid/ofaa439.826

Ejemplares similares